Two Sigma Investments
TRIL

Two Sigma Investments’s Trillium Therapeutics Inc. TRIL Stock Holding History

Two Sigma Investments’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-97,400
Closed -$1.38M – 3917
2020
Q3 		$1.38M Buy
97,400
+26,500
+37% +$264K ﹤0.01% 1542
2020
Q2 		$574K Buy
+70,900
New +$439K ﹤0.01% 1909
2019
Q4 		– Sell
-24,138
Closed -$7K – 4107
2019
Q3 		$7K Sell
24,138
-2,300
-9% -$777 ﹤0.01% 3391
2019
Q2 		$9K Sell
26,438
-27,290
-51% -$14.1K ﹤0.01% 3269
2019
Q1 		$35K Buy
53,728
+33,428
+165% +$40.9K ﹤0.01% 2950
2018
Q4 		$35K Buy
+20,300
New +$60.9K ﹤0.01% 2877

Other funds holding TRIL

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Two Sigma Investments's TRIL Position: Q4 2020 in Review

Two Sigma Investments sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2020, closing a stake of 97,400 shares — an estimated $1.38M sold.

Two Sigma Investments first reported a position in TRIL in Q4 2018 and held it in 6 quarters. The position peaked at $1.38M in Q3 2020. 131 funds tracked by Wall St. Rank hold TRIL as of Q4 2020.

  • Two Sigma Investments reported no remaining Trillium Therapeutics Inc. position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Investments sold 97,400 Trillium Therapeutics Inc. shares in Q4 2020, an estimated $1.38M.
  • Two Sigma Investments first reported a position in Trillium Therapeutics Inc. in Q4 2018 and held it in 6 quarters.
  • Two Sigma Investments's Trillium Therapeutics Inc. position peaked at $1.38M in Q3 2020.
  • 131 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2020.

Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.